TheProfitWatch

ERNA - Ernexa Therapeutics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.25 0.08 (6.41%) --- --- 0.0 (0.0%) 0.0 (0.0%) 0.08 (6.41%) 0.0 (0.0%) -0.01 (-0.94%)

Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.15
Diluted EPS:
-0.15
Basic P/E:
-8.8673
Diluted P/E:
-8.8673
RSI(14) 1m:
100.0
VWAP:
1.33
RVol:

Events

Period Kind Movement Occurred At

Related News